Pfizer wins more docs in preliminary discovery saga over Enbrel biosimilar

Intellectual Property 2021-11-18 12:46 pm By Christine Caulfield | Melbourne

Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.